1 Subbe CP, "Validation of a modified early warning score in medical admissions" 94 : 521-526, 2001
2 Rhodes A, "The surviving sepsis campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)" 41 : 1620-1628, 2015
3 Merion RM, "The survival benefit of liver transplantation" 5 : 307-313, 2005
4 Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine" 22 : 707-710, 1996
5 Williams JM, "Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection" 151 : 586-596, 2017
6 Rhodes A, "Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. 2016" 43 : 304-377, 2017
7 Levy MM, "Surviving sepsis campaign : association between performance metrics and outcomes in a 7. 5-year study" 40 : 1623-1633, 2014
8 Bajaj JS, "Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience" 56 : 2328-2335, 2012
9 Innocenti F, "SOFA score in septic patients : incremental prognostic value over age, comorbidities, and parameters of sepsis severity" 13 : 405-412, 2019
10 Bruns T, "Risk factors and outcome of bacterial infections in cirrhosis" 20 : 2542-2554, 2014
1 Subbe CP, "Validation of a modified early warning score in medical admissions" 94 : 521-526, 2001
2 Rhodes A, "The surviving sepsis campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)" 41 : 1620-1628, 2015
3 Merion RM, "The survival benefit of liver transplantation" 5 : 307-313, 2005
4 Vincent JL, "The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine" 22 : 707-710, 1996
5 Williams JM, "Systemic inflammatory response syndrome, quick sequential organ function assessment, and organ dysfunction: insights from a prospective database of ED patients with infection" 151 : 586-596, 2017
6 Rhodes A, "Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. 2016" 43 : 304-377, 2017
7 Levy MM, "Surviving sepsis campaign : association between performance metrics and outcomes in a 7. 5-year study" 40 : 1623-1633, 2014
8 Bajaj JS, "Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience" 56 : 2328-2335, 2012
9 Innocenti F, "SOFA score in septic patients : incremental prognostic value over age, comorbidities, and parameters of sepsis severity" 13 : 405-412, 2019
10 Bruns T, "Risk factors and outcome of bacterial infections in cirrhosis" 20 : 2542-2554, 2014
11 Churpek MM, "Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit" 195 : 906-911, 2017
12 Raith EP, "Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit" 317 : 290-300, 2017
13 Thabut D, "Model for endstage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure" 46 : 1872-1882, 2007
14 Galbois A, "Improved prognosis of septic shock in patients with cirrhosis : a multicenter study" 42 : 1666-1675, 2014
15 Shankar-Hari M, "Developing a new definition and assessing new clinical criteria for septic shock : for the third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3)" 315 : 775-787, 2016
16 Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine" 101 : 1644-1655, 1992
17 Jalan R, "Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013" 60 : 1310-1324, 2014
18 Fernandez J, "Bacterial infections in cirrhosis : epidemiological changes with invasive procedures and norfloxacin prophylaxis" 35 : 140-148, 2002
19 Seymour CW, "Assessment of clinical criteria for sepsis: for the third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)" 315 : 762-774, 2016
20 Donnelly JP, "Application of the Third International Consensus Definitions for Sepsis(Sepsis-3)Classification : a retrospective population-based cohort study" 17 : 661-670, 2017
21 Levy MM, "2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference" 29 : 530-538, 2003